|
11 |
Long-term results of PARPi as maintenance in front-line
|
Antonio González Martín |
2022-11-10 |
42 |
|
10 |
The incorporation of HPV testing for cervical cancer screening: The What, Why, and How?
|
Warner K. Huh |
2022-04-26 |
40 |
|
9 |
Bio- and GenomeBank Denmark (RBGB) including the danish cancerbiobank
|
Estrid Hoegdall |
2022-04-26 |
8 |
|
8 |
Recent progress of precision medicine in ovarian cancer
|
Andreas du Bois |
2022-04-26 |
17 |
|
7 |
Overcoming homologous recombination proficiency in ovarian cancer
|
Aikou Okamoto |
2022-04-26 |
10 |
|
6 |
Recurrent ovarian cancer: when does surgery make a difference?
|
Ginger J. Gardner |
2022-04-26 |
12 |
|
5 |
Impact of COVID-19 on the care of gynecologic cancer patients requiring surgery
|
Sudha Sundar |
2021-04-17 |
20 |
|
4 |
Drug repositioning for ovarian cancer targeting mevalonate pathway
|
Yusuke Kobayashi |
2021-04-17 |
8 |
|
3 |
Multi-Omics and therapeutically applicable research of ovarian cancer
|
Gang Chen |
2021-04-17 |
9 |
|
2 |
Machine learning-based predictive model for parametrial invasion in patients with early-stage cervical cancer
|
Kittipat Charoenkwan |
2021-04-17 |
8 |
